Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Advantage Arrest in Children with Dental Caries
NCT05670743Phase 2Completed
- Sponsor
- Advantage Silver Dental Arrest, LLC
- Start
- Mar 2023
- Primary completion
- Jun 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of silver diamine fluoride in dental caries, sponsored by Advantage Silver Dental Arrest, LLC. Primary endpoints: Maximum Plasma Concentration of Fluoride at 21 days, Maximum Plasma Concentration of Silver at 21 days and 4 more. Started Mar 2023; status: completed.
02
Drugs
silver diamine fluoride
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT05670743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670743.